Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.52 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.52 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.52 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | HTR1B | P28222 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138195 | 1.00 | KMT2A (0.61) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL17138156 | 1.00 | KMT2A (0.61) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL9716543 | 1.00 | KMT2A (0.61) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL10407331 | 0.98 | KMT2A (0.60) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL9716532 | 0.94 | KMT2A (0.56) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL17138157 | 0.93 | KMT2A (0.54) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL29000081 | 0.92 | KMT2A (0.55) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL8846918 | 0.92 | KMT2A (0.57) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL8430064 | 0.92 | KMT2A (0.57) | KMT2AMEN1ALDH1A1MAPK1TDP1 | |
| SCHEMBL30125136 | 0.92 | KMT2A (0.57) | KMT2AMEN1ALDH1A1MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | KMT2A 580/4885MEN1 4684/4885ALDH1A1 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.